Dendritic cell function after gene transfer with adenovirus-calcium phosphate co-precipitates

Molecular Therapy

Volumn 15, Issue 2, 2007, Pages 386-392

  Seiler, Michael P ^a   Gottschalk, Stephen ^a,b   Cerullo, Vincenzo ^a   Ratnayake, Maheshika ^a,b   Mane, Viraj P ^a   Clarke, Christian ^a   Palmer, Donna J ^a   Ng, Philip ^a   Rooney, Cliona M ^a,b   Lee, Brendan ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b CENTER FOR CELL AND GENE THERAPY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; CALCIUM PHOSPHATE; CD40 ANTIGEN; CD86 ANTIGEN; CYTOKINE; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADOPTIVE IMMUNOTHERAPY; ANIMAL CELL; ARTICLE; CELL ACTIVATION; CELL FUNCTION; CELL MATURATION; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOMEGALOVIRUS; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; ENDOSOME; FEMALE; GENE EXPRESSION; GENE TRANSFER; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PRECIPITATION;

ADENOVIRIDAE; ANIMALS; BONE MARROW CELLS; CALCIUM PHOSPHATES; CAPSID PROTEINS; DENDRITIC CELLS; FEMALE; FLOW CYTOMETRY; GENETIC VECTORS; HUMANS; INTEGRINS; MICE; MICE, INBRED BALB C; PROTEIN BINDING; T-LYMPHOCYTES; TRANSFECTION;

ADENOVIRIDAE; CYTOMEGALOVIRUS; HUMAN ADENOVIRUS TYPE 5;

EID: 33846280508     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/sj.mt.6300029     Document Type: Article

References (50)

1. Steinman, RM and Nussenzweig, MC (2002). Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance. Proc Natl Acad Sci USA 99: 351-358.
2. O'neill, DW, Adams, S and Bhardwaj, N (2004). Manipulating dendritic cell biology for the active immunotherapy of cancer. Blood 104: 2235-2246.
3. Lu, L and Thomson, AW (2002). Manipulation of dendritic cells for tolerance induction in transplantation and autoimmune disease. Transplantation 73: S19-S22.
4. Wakkach, A et al. (2003). Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo. Immunity 18: 605-617.
5. Steinman, RM, Hawiger, D and Nussenzweig, MC (2003). Tolerogenic dendritic cells. Annu Rev Immunol 21: 685-711.
6. Carbone, FR, Belz, GT and Heath, WR (2004). Transfer of antigen between migrating and lymph node-resident DCs in peripheral T-cell tolerance and immunity. Trends Immunol 25: 655-658.
7. Saudemont, A, Corm, S, Wickham, T, Hetuin, D and Quesnel, B (2005). Induction of leukemia-specific CD8+ cytotoxic T cells with autologous myeloid leukemic cells maturated with a fiber-modified adenovirus encoding TNF-alpha. Mol Ther 11: 950-959.
8. Blattman, JN and Greenberg, PD (2004). Cancer immunotherapy: A treatment for the masses. Science 305: 200-205.
9. Mcconnell, MJ and Imperiale, MJ (2004). Biology of adenovirus and its use as a vector for gene therapy. Hum Gene Ther 15: 1022-1033.
10. Stockwin, LH et al. (2002). Engineered expression of the Coxsackie B and adenovirus receptor (CAR) in human dendritic cells enhances recombinant adenovirus-mediated gene transfer. J Immunol Methods 259: 205-215.
11. Kita-Furuyama, M et al. (2003). Dendritic cells infected with adenovirus expressing the thyrotrophin receptor induce Graves' hyperthyroidism in BALB/c mice. Clin Exp Immunol 131: 234-240.
12. Tillman, BW et al. (1999). Maturation of dendritic cells accompanies high-efficiency gene transfer by a CD40-targeted adenoviral vector. J Immunol 162: 6378-6383.
13. Worgall, S et al. (2004). Modification to the capsid of the adenovirus vector that enhances dendritic cell infection and transgene-specific cellular immune responses. J Virol 78: 2572-2580.
14. Maguire, CA et al. (2006). Recombinant adenovirus type 5 vectors that target DCSIGN, ChemR23 and alpha(v)beta3 integrin efficiently transduce human dendritic cells and enhance presentation of vectored antigens. Vaccine 24: 671-682.
15. Gong, J et al. (1997). Induction of antigen-specific antitumor immunity with adenovirus-transduced dendritic cells. Gene Ther 4: 1023-1028.
16. Zhong, L, Granelli-Piperno, A, Choi, Y and Steinman, RM (1999). Recombinant adenovirus is an efficient and non-perturbing genetic vector for human dendritic cells. Eur J Immunol 29: 964-972.
17. Jonuleit, H et al. (2000). Efficient transduction of mature CD83+ dendritic cells using recombinant adenovirus suppressed T cell stimulatory capacity. Gene Ther 7: 249-254.
18. Rea, D et al. (2001). Highly efficient transduction of human monocyte-derived dendritic cells with subgroup B fiber-modified adenovirus vectors enhances transgene-encoded antigen presentation to cytotoxic T cells. J Immunol 166: 5236-5244.
19. Ophorst, OJ et al. (2004). An adenoviral type 5 vector carrying a type 35 fiber as a vaccine vehicle: DC targeting, cross neutralization, and immunogenicity. Vaccine 22: 3035-3044.
20. Okada, N et al. (2001). Efficient gene delivery into dendritic cells by fiber-mutant adenovirus vectors. Biochem Biophys Res Commun 282: 173-179.
21. Pereboev, AV et al. (2004). Enhanced gene transfer to mouse dendritic cells using adenoviral vectors coated with a novel adapter molecule. Mol Ther 9: 712-720.
22. Mellman, I and Steinman, RM (2001). Dendritic cells: Specialized and regulated antigen processing machines. Cell 106: 255-258.
23. Philpott, NJ, Nociari, M, Elkon, KB and Falck-Pedersen, E (2004). Adenovirusinduced maturation of dendritic cells through a PI3 kinase-mediated TNF-alpha induction pathway. Proc Natl Acad Sci USA 101: 6200-6205.
24. Hirschowitz, EA, Weaver, JD, Hidalgo, GE and Doherty, DE (2000). Murine dendritic cells infected with adenovirus vectors show signs of activation. Gene Ther 7: 1112-1120.
25. Okada, N et al. (2003). Gene transduction efficiency and maturation status in mouse bone marrow-derived dendritic cells infected with conventional or RGD fiber-mutant adenovirus vectors. Cancer Gene Ther 10: 421-431.
26. Bai, M, Harfe, B and Freimuth, P (1993). Mutations that alter an Arg-Gly-Asp (RGD) sequence in the adenovirus type 2 penton base protein abolish its cell-rounding activity and delay virus reproduction in flat cells. J Virol 67: 5198-5205.
27. Shayakhmetov, DM, Eberly, AM, Li, ZY and Lieber, A (2005). Deletion of penton RGD motifs affects the efficiency of both the internalization and the endosome escape of viral particles containing adenovirus serotype 5 or 35 fiber knobs. J Virol 79: 1053-1061.
28. Mosca, PJ, Clay, TM, Kim Lyerly, H and Morse, MA (2003). Current status of dendritic cell immunotherapy of malignancies. Int Rev Immunol 22: 255-281.
29. Zaia, JA et al. (2000). Status of cytomegalovirus prevention and treatment in 2000. Hematology (Am Soc Hematol Educ Program) 1: 339-355.
30. Chakrabarti, S et al. (2002). High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: Potential role of Campath-1H in delaying immune reconstitution. Blood 99: 4357-4363.
31. Riddell, SR et al. (1992). Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones. Science 257: 238-241.
32. Bollard, CM et al. (2004). The generation and characterization of LMP2-specific CTLs for use as adoptive transfer from patients with relapsed EBV-positive Hodgkin disease. J Immunother 27: 317-327.
33. Foster, AE et al. (2004). A comparison of gene transfer and antigen-loaded dendritic cells for the generation of CD4+ and CD8+ cytomegalovirus-specific T cells in HLA-A2+ and HLA-A2- donors. Biol Blood Marrow Transplant 10: 761-771.
34. Gottschalk, S, Heslop, HE and Rooney, CM (2005). Adoptive immunotherapy for EBV-associated malignancies. Leuk Lymphoma 46: 1-10.
35. Eisenstein, M (2005). A look back: Fast, cheap and under control. Nat Meth 2: 318.
36. Varga, CM et al. (2005). Quantitative comparison of polyethylenimine formulations and adenoviral vectors in terms of intracellular gene delivery processes. Gene Ther 12: 1023-1032.
37. Campbell, EM and Hope, TJ (2005). Gene therapy progress and prospects: viral trafficking during infection. Gene Ther 12: 1353-1359.
38. Fasbender, A et al. (1998). Incorporation of adenovirus in calcium phosphate precipitates enhances gene transfer to airway epithelia in vitro and in vivo. J Clin Invest 102: 184-193.
39. Yi, SM, Lee, JH, Graham, S, Zabner, J and Welsh, MJ (2001). Adenovirus calcium phosphate coprecipitates enhance squamous cell carcinoma gene transfer. Laryngoscope 111: 1290-1296.
40. Tomko, RP, Xu, R and Philipson, L (1997). HCAR and MCAR: The human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses. Proc Natl Acad Sci USA 94: 3352-3356.
41. Roelvink, PW, Mi Lee, G, Einfeld, DA, Kovesdi, I and Wickham, TJ (1999). Identification of a conserved receptor-binding site on the fiber proteins of CAR-recognizing adenoviridae. Science 286: 1568-1571.
42. Wickham, TJ, Mathias, P, Cheresh, DA and Nemerow, GR (1993). Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment. Cell 73: 309-319.
43. Chiu, CY, Mathias, P, Nemerow, GR and Stewart, PL (1999). Structure of adenovirus complexed with its internalization receptor, alphavbeta5 integrin. J Virol 73: 6759-6768.
44. Molinier-Frenkel, V et al. (2003). The maturation of murine dendritic cells induced by human adenovirus is mediated by the fiber knob domain. J Biol Chem 278: 37175-37182.
45. Schoggins, JW, Nociari, M, Philpott, N and Falck-Pedersen, E (2005). Influence of fiber detargeting on adenovirus-mediated innate and adaptive immune activation. J Virol 79: 11627-11637.
46. Iacobelli-Martinez, M, Nepomuceno, RR, Connolly, J and Nemerow, GR (2005). CD46-utilizing adenoviruses inhibit C/EBPbeta-dependent expression of proinflammatory cytokines. J Virol 79: 11259-11268.
47. Inaba, K et al. (1992). Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colonystimulating factor. J Exp Med 176: 1693-1702.
48. Leen, AM et al. (2004). Fiber-modified adenoviruses generate subgroup crossreactive, adenovirus-specific cytotoxic T lymphocytes for therapeutic applications. Blood 103: 1011-1019.
49. Sili, U et al. (2003). Large-scale expansion of dendritic cell-primed polyclonal human cytotoxic T-lymphocyte lines using lymphoblastoid cell lines for adoptive immunotherapy. J Immunother 26: 241-256.
50. Ng, P and Graham, FL (2002). Construction of first-generation adenoviral vectors. Methods Mol Med 69: 389-414.